InsideArbitrage Event Driven Monitor – June 27, 2023

  • June 27, 2023
Subscribe to receive our Event Driven Monitor by email every morning before the market opens. Merger Arbitrage AMED: Amedisys, Inc. (AMED) enters into a definitive agreement to be acquired by UnitedHealth Group Incorporated (UNH) for $3.8 billion or $101 per share in cash, after terminating its previous agreement with Option Care Health (OPCH). ISEE: IVERIC bio announced that the required waiting period under the HSR Act with respect to the merger with Astellas Pharma expired on June 23, 2023. CTIC: Swedish Orphan Biovitrum AB completes the acquisition of CTI BioPharma Corp. XM: Qualtrics International (XM) received all regulatory approvals or clearances required in connection with the previously announced merger with Silver Lake, representing the last of the closing conditions under the Merger Agreement to be satisfied. The company expects the merger to close on June 28, 2023. VECT: VectivBio Holding AG announced that it has received shareholder approval to be acquired by Ironwood Pharmaceuticals (IRWD). EMBK: Embark Technology announced that the special meeting of stockholders will be on July 17, 2023. You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here. Deal in the Works FREE: According to a regulatory filing, Whole Earth Brands’ (FREE)...

Only plus or premium subscribers can access this post. Subscribe today.